News on bioinformatics, software, genome analysis, variant classification, and IT in genetics, genomics, and molecular diagnostics.
The companies aim to develop microbiome diagnostic assays for colon cancer and other gastrointestinal diseases including irritable bowel syndrome.
The clinical trial matching app, which Roche collaborated on with MolecularMatch, is the latest in a series of features that it will introduce in its tumor board solution.
The company will use the funds to develop and refine proprietary algorithms for identifying more complex variants including translocations and inversions.
British software firm Congenica is partnering with Hong Kong's Digital China Health Technologies to expand its clinical genomics interpretation business in China.
The planned program is part of beta test of Repositive’s Cancer Models platform which connects biopharmaceutical companies and contract research organizations.
